InvestorsHub Logo
Followers 5
Posts 593
Boards Moderated 0
Alias Born 06/11/2010

Re: grandma_of_jbraika post# 41373

Monday, 12/16/2013 7:26:35 AM

Monday, December 16, 2013 7:26:35 AM

Post# of 80490

"There are many ways of reporting the safety data from a dataset that includes clinical trials with multiple observation points as well as the experience of commercial patients," said DewDiligence

The FDA has the authority to have the safety data reported the way it wants in order to justify its action. This is probably what in DewDiligence's mind. DewDiligence supports the FDA's action, doesn't he? So does Novartis and the other poster who always speaks for Novartis.

Has DewDiligence been ever positive on Ariad?

There are many ways of reporting the safety data from a dataset. Dew is right. At least there are 2 ways, I have observed.

One way is to follow standard criteria and categorize adverse events scientifically as the clinical trial doctors and Ariad have done.

Another way is to intentionally violate standard criteria and create confusion and questions as the FDA has done to Iclusig, as the result of which, a lifesaving drug can be withdrawn, the lifesaving drug company can be destroyed, doctors fear their patients are going to die, and patients panic.
-----
If Harvey Berger's legal team acts against the FDA, I will vote him for the greatest CEO of all time.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=94997236
-----
DewDiligence, how is your Novartis Ariad Killer going?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.